Your browser doesn't support javascript.
loading
ABCG2/BCRP transport mechanism revealed through kinetically excited targeted molecular dynamics simulations.
Dudas, B; Decleves, X; Cisternino, S; Perahia, D; Miteva, M A.
Afiliação
  • Dudas B; Inserm U1268 MCTR, CiTCoM UMR 8038 CNRS, Université Paris Cité, Paris, France.
  • Decleves X; Laboratoire de Biologie et Pharmacologie Appliquée, Ecole Normale Supérieure Paris-Saclay, Gif-sur-Yvette, France.
  • Cisternino S; Inserm UMRS 1144, Optimisation Thérapeutique en Neuropsychopharmacologie - Université Paris Cité, Paris, France.
  • Perahia D; Biologie du Médicament et Toxicologie, Assistance Publique Hôpitaux de Paris, AP-HP, Hôpital Universitaire Cochin, Paris, France.
  • Miteva MA; Inserm UMRS 1144, Optimisation Thérapeutique en Neuropsychopharmacologie - Université Paris Cité, Paris, France.
Comput Struct Biotechnol J ; 20: 4195-4205, 2022.
Article em En | MEDLINE | ID: mdl-36016719
ABSTRACT
ABCG2/BCRP is an ABC transporter that plays an important role in tissue protection by exporting endogenous substrates and xenobiotics. ABCG2 is of major interest due to its involvement in multidrug resistance (MDR), and understanding its complex efflux mechanism is essential to preventing MDR and drug-drug interactions (DDI). ABCG2 export is characterized by two major conformational transitions between inward- and outward-facing states, the structures of which have been resolved. Yet, the entire transport cycle has not been characterized to date. Our study bridges the gap between the two extreme conformations by studying connecting pathways. We developed an innovative approach to enhance molecular dynamics simulations, 'kinetically excited targeted molecular dynamics', and successfully simulated the transitions between inward- and outward-facing states in both directions and the transport of the endogenous substrate estrone 3-sulfate. We discovered an additional pocket between the two substrate-binding cavities and found that the presence of the substrate in the first cavity is essential to couple the movements between the nucleotide-binding and transmembrane domains. Our study shed new light on the complex efflux mechanism, and we provided transition pathways that can help to identify novel substrates and inhibitors of ABCG2 and probe new drug candidates for MDR and DDI.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Comput Struct Biotechnol J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Comput Struct Biotechnol J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França